课题基金 / 基金详情

Fred Hutchinson Cancer Research Center Lung SPORE

Fred Hutchinson Cancer Research Center Lung SPORE
Fred Hutchinson 癌症研究中心肺孢子
批准号:
10436169
负责人:
A McGarry Houghton
金额:
$244.71万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-01 至 2024-05-31
关键词:
AddressAntigensAtypical lymphocyteAutologousBenignBioinformaticsBiological MarkersBiometryCREBBP geneCancer EtiologyCancer PatientCell LineageCessation of lifeChromatinClinicalColoradoData SetDevelopmentDiagnosisDiagnosticEvaluationFred Hutchinson Cancer Research CenterGenesGenetic DeterminismGenotypeGoalsGoldHistopathologyHybridsImage AnalysisImmune checkpoint inhibitorImmune responseImmunotherapyInfrastructureKDM1A geneLungLung CAT ScanLung noduleLymphocyteMalignant - descriptorMalignant neoplasm of lungMedicalMethodologyModelingMutationNeoplasm Circulating CellsNivolumabNon-Small-Cell Lung CarcinomaOncogenesOperative Surgical ProceduresPatient-Focused OutcomesPatientsPerformancePhase I Clinical TrialsPhase II Clinical TrialsPlasmaPrognosisProteinsResearchResearch DesignResearch PersonnelResearch Project GrantsResourcesSpecimenSurvival RateT cell therapyT-LymphocyteTestingTherapeuticTimeTranslational ResearchVaccinesX-Ray Computed Tomographyantagonistantigen testbasebench to bedsidecancer cellcancer immunotherapycareercheckpoint therapyclinical carecohortearly screeningeffective therapyhuman tissueimaging biomarkerimprovedindustry partnerinhibitorinnovationlung cancer screeninglung small cell carcinomamouse modelneoantigensneutrophilnovelpatient derived xenograft modelpatient responseprogramsradiological imagingradiomicsreceptorresponserisk prediction modelrisk stratificationscreeningsuccesstherapeutic targettranslational cancer researchtreatment responsetumortumor microenvironment

项目摘要

项目成果

A McGarry Houghton的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract – Overall The Fred Hutch Lung SPORE consists of four innovative projects, three supportive cores, and the required Developmental Research Program and Career Enhancement Program. We have leveraged the strengths of the investigators and our Center to tackle three critical barriers precluding meaningful improvements in lung cancer survival rates: facilitation of pulmonary nodule evaluation for lung cancer early detection and screening, lack of effective therapies for small cell lung cancer (SCLC), and the sub-optimal response rates of non-small cell lung cancer (NSCLC) patients to novel immune-based therapies. To overcome these barriers, we propose the following four projects: 1) Targeting the Neutrophil Lineage to Enhance Immune Checkpoint Inhibitor Efficacy in NSCLC, 2) Targeting Neoantigens for Lung Cancer Immunotherapy, 3) Identifying Determinants of Sensitivity to LSD1 Inhibition in SCLC, and 4) Risk Stratification for Pulmonary Nodules Detected by CT Imaging Using Plasma and Imaging Biomarkers. These projects will be supported by an Administrative Core, a Biostatistics and Bioinformatics Core (BBC), and a Histopathology and Biospecimen Core (HBC).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neutrophil derived proteinases abolish the IFNG signature in NSCLC
  • 批准号:
    10717448
  • 项目类别:
  • 资助金额:
    $57.31万
  • 财政年份:
    2023
  • 负责人:
    A McGarry Houghton
  • 依托单位:
Anxa2 drives the function of immune suppressive neutrophils in lung cancer
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
  • 批准号:
    10301566
  • 项目类别:
  • 资助金额:
    $66.03万
  • 财政年份:
    2021
  • 负责人:
    A McGarry Houghton
  • 依托单位:
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
  • 批准号:
    10700944
  • 项目类别:
  • 资助金额:
    $38.98万
  • 财政年份:
    2021
  • 负责人:
    A McGarry Houghton
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究